Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' BORG A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 148 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Salahshor, S; Lei, HX; Huo, HG; Kristensen, VN; Loman, N; Sjoberg-Margolin, S; Borg, A; Borresen-Dale, AL; Vorechovsky, I; Lindblom, A
      Low frequency of E-cadherin alterations in familial breast cancer

      BREAST CANCER RESEARCH
    2. Arver, B; Borg, A; Lindblom, A
      First BRCA1 and BRCA2 gene testing implemented in the health care system of Stockholm

      GENETIC TESTING
    3. Borg, A
      Hereditary prostate cancer: a new piece of the puzzle

      NATURE MEDICINE
    4. Hashemi, J; Bendahl, PO; Sandberg, T; Platz, A; Linder, S; Stierner, U; Olsson, H; Ingvar, C; Hansson, J; Borg, A
      Haplotype analysis and age estimation of the 113insR CDKN2A founder mutation in Swedish melanoma families

      GENES CHROMOSOMES & CANCER
    5. Gronberg, H; Ahman, AK; Emanuelsson, M; Bergh, A; Damber, JE; Borg, A
      BRCA2 mutation in a family with hereditary prostate cancer

      GENES CHROMOSOMES & CANCER
    6. Borg, A
      Molecular and pathological characterization of inherited breast cancer

      SEMINARS IN CANCER BIOLOGY
    7. Vallon-Christersson, J; Cayanan, C; Haraldsson, K; Loman, N; Bergthorsson, JT; Brondum-Nielsen, K; Gerdes, AM; Moller, P; Kristoffersson, U; Olsson, H; Borg, A; Monteiro, ANA
      Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families

      HUMAN MOLECULAR GENETICS
    8. Moller, P; Borg, A; Heimdal, K; Apold, J; Vallon-Christersson, J; Hovig, E; Maehle, L
      The BRCA1 syndrome and other inherited breast or breast-ovarian cancers ina Norwegian prospective series

      EUROPEAN JOURNAL OF CANCER
    9. Moller, P; Heimdal, K; Apold, J; Fredriksen, A; Borg, A; Hovig, E; Hagen, A; Hagen, B; Pedersen, JC; Maehle, L
      Genetic epidemiology of BRCA1 mutations in Norway

      EUROPEAN JOURNAL OF CANCER
    10. Borg, A; Bolinder, J; Fuchs, L
      Simultaneous velocity and concentration measurements in the near field of a turbulent low-pressure jet by digital particle image velocimetry-planar laser-induced fluorescence

      EXPERIMENTS IN FLUIDS
    11. Koul, A; Loman, N; Malander, S; Borg, A; Ridderheim, M
      Two BRCA1-positive epithelial ovarian tumors with metastases to the central nervous system: A case report

      GYNECOLOGIC ONCOLOGY
    12. Ramsvik, T; Borg, A; Kildemo, M; Raaen, S; Matsuura, A; Jaworowski, AJ; Worren, T; Leandersson, M
      Molecular vibrations in core-ionised CO adsorbed on Co(0001) and Rh(100)

      SURFACE SCIENCE
    13. Ronning, M; Bergene, E; Borg, A; Ausen, S; Holmen, A
      Scanning tunnelling microscopic studies on the adsorption and decomposition of ethene on the reconstructed Pt(100)-hex-R0.7 degrees surface

      SURFACE SCIENCE
    14. Hedenfalk, I; Duggan, D; Chen, YD; Radmacher, M; Bittner, M; Simon, R; Meltzer, P; Gusterson, B; Esteller, M; Kallioniemi, OP; Wilfond, B; Borg, A; Trent, J
      Gene-expression profiles in hereditary breast cancer.

      NEW ENGLAND JOURNAL OF MEDICINE
    15. Bergthorsson, JT; Ejlertsen, B; Olsen, JH; Borg, A; Nielsen, KV; Barkardottir, RB; Klausen, S; Mouridsen, HT; Winther, K; Fenger, K; Niebuhr, A; Harboe, TL; Niebuhr, E
      BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age

      JOURNAL OF MEDICAL GENETICS
    16. Rose, MK; Borg, A; Mitsui, T; Ogletree, DF; Salmeron, M
      Subsurface impurities in Pd(111) studied by scanning tunneling microscopy

      JOURNAL OF CHEMICAL PHYSICS
    17. Gentile, M; Wiman, A; Thorstenson, S; Loman, N; Borg, A; Wingren, S
      Deletion mapping of chromosome segment 11q24-q25, exhibiting extensive allelic loss in early onset breast cancer

      INTERNATIONAL JOURNAL OF CANCER
    18. Borg, A
      Picturing the past: English history in text and image, 1830-1870

      ENGLISH HISTORICAL REVIEW
    19. Borg, A
      The martial arts of Renaissance Europe

      ENGLISH HISTORICAL REVIEW
    20. Gruvberger, S; Ringner, M; Chen, YD; Panavally, S; Saal, LH; Borg, A; Ferno, M; Peterson, C; Meltzer, PS
      Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns

      CANCER RESEARCH
    21. Staff, S; Isola, JJ; Johannsson, O; Borg, A; Tanner, MM
      Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa

      BRITISH JOURNAL OF CANCER
    22. Borg, A
      Universal literacy - A challenge for computing in the 21st Century

      COMMUNICATIONS OF THE ACM
    23. Olsson, H; Andersson, H; Bladstrom, A; Borg, A; Ingvar, C; Moller, T; Westerdahl, J
      Re: High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families - Response

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    24. Loman, N; Johannsson, O; Kristoffersson, U; Olsson, H; Borg, A
      Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutationsin a population-based series of early-onset breast cancer

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    25. Tanner, MM; Grenman, S; Koul, A; Johannsson, O; Meltzer, P; Pejovic, T; Borg, A; Isola, JJ
      Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer

      CLINICAL CANCER RESEARCH
    26. Koul, A; Malander, S; Loman, N; Pejovic, T; Heim, S; Willen, R; Johannson, O; Olsson, H; Ridderheim, M; Borg, A
      BRCA1 and BRCA2 mutations in ovarian cancer: Covariation with specific cytogenetic features

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    27. Planck, M; Wenngren, E; Borg, A; Olsson, H; Nilbert, M
      Somatic frameshift alterations in mononucleotide repeat-containing genes in different tumor types from an HNPCC family with germline MSH2 mutation

      GENES CHROMOSOMES & CANCER
    28. Staff, S; Nupponen, NN; Borg, A; Isola, JJ; Tanner, MM
      Multiple copies of mutant BRCA1 and BRCA2 alleles in breast tumors from germ-line mutation carriers

      GENES CHROMOSOMES & CANCER
    29. Sarantaus, L; Huusko, P; Eerola, H; Launonen, V; Vehmanen, P; Rapakko, K; Gillanders, E; Syrjakoski, K; Kainu, T; Vahteristo, P; Krahe, R; Paakkonen, K; Hartikainen, J; Blomqvist, C; Lopponen, T; Holli, K; Ryynanen, M; Butzow, R; Borg, A; Arver, BW; Holmberg, E; Mannermaa, A; Kere, J; Kallioniemi, OP; Winqvist, R; Nevanlinna, H
      Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland

      EUROPEAN JOURNAL OF HUMAN GENETICS
    30. Jonsson, M; Borg, A; Nilbert, M; Andersson, T
      Involvement of adenomatous polyposis coli (APC)/beta-catenin signalling inhuman breast cancer

      EUROPEAN JOURNAL OF CANCER
    31. Loman, N; Johannsson, A; Bendahl, PO; Dahl, N; Einbeigi, Z; Gerdes, AM; Borg, A; Olsson, H
      Prognosis and clinical presentation of BRCA2-associated breast cancer

      EUROPEAN JOURNAL OF CANCER
    32. Stal, O; Borg, A; Ferno, M; Kallstrom, AC; Malmstrom, P; Nordenskjold, B
      ErbB2 status and the benefit from two or five years of adjuvant tamoxifen in postmenopausal early stage breast cancer

      ANNALS OF ONCOLOGY
    33. Adeyinka, A; Mertens, F; Bondeson, L; Garne, JP; Borg, A; Baldetorp, B; Pandis, N
      Cytogenetic heterogeneity and clonal evolution in synchronous bilateral breast carcinomas and their lymph node metastases from a male patient withoutany detectable BRCA2 germline mutation

      CANCER GENETICS AND CYTOGENETICS
    34. Ramstad, A; Strisland, F; Ramsvik, T; Borg, A
      CO adsorption on the Pt/Rh(100) surface studied by high-resolution photoemission

      SURFACE SCIENCE
    35. Kainu, T; Juo, SHH; Desper, R; Schaffer, AA; Gillanders, E; Rozenblum, E; Freas-Lutz, D; Weaver, D; Stephan, D; Bailey-Wilson, J; Kallioniemi, OP; Tirkkonen, M; Syrjakoski, K; Kuukasjarvi, T; Koivisto, P; Karhu, R; Holli, K; Arason, A; Johannesdottir, G; Bergthorsson, JT; Johannsdottir, H; Egilsson, V; Barkardottir, RB; Johannsson, O; Haraldsson, K; Sandberg, T; Holmberg, E; Gronberg, H; Olsson, H; Borg, A; Vehmanen, P; Eerola, H; Heikkila, P; Pyrhonen, S; Nevanlinna, H
      Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    36. Borg, A; Isola, J; Chen, JD; Rubio, C; Johansson, U; Werelius, B; Lindblom, A
      Germline BRCAl and hMLHl mutations in a family with male and female breastcarcinoma

      INTERNATIONAL JOURNAL OF CANCER
    37. Borg, A
      The metropolis and its image: Constructing identities for London, c.1750-1950

      ENGLISH HISTORICAL REVIEW
    38. Kauraniemi, P; Hedenfalk, I; Persson, K; Duggan, DJ; Tanner, M; Johannsson, O; Olsson, H; Trent, JM; Isola, J; Borg, A
      MYB oncogene amplification in hereditary BRCA1 breast cancer

      CANCER RESEARCH
    39. Fuqua, SAW; Wiltschke, C; Zhang, QX; Borg, A; Castles, CG; Friedrichs, WE; Hopp, T; Hilsenbeck, S; Mohsin, S; O'Connell, P; Allred, DC
      A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions

      CANCER RESEARCH
    40. Mineta, H; Miura, K; Ogino, T; Takebayashi, S; Misawa, K; Ueda, Y; Suzuki, I; Dictor, M; Borg, A; Wennerberg, J
      Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas

      BRITISH JOURNAL OF CANCER
    41. Jarvinen, TAH; Tanner, M; Rantanen, V; Barlund, M; Borg, A; Grenman, S; Isola, J
      Amplification and deletion of topoisomerase II alpha associate with ErbB-2amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer

      AMERICAN JOURNAL OF PATHOLOGY
    42. Moses, EK; Lade, JA; Guo, GL; Wilton, AN; Grehan, M; Freed, K; Borg, A; Terwilliger, JD; North, R; Cooper, DW; Brennecke, SP
      A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2

      AMERICAN JOURNAL OF HUMAN GENETICS
    43. Mazoyer, S; Leary, J; Kirk, J; Fleischmann, E; Wagner, T; Claes, K; Messiaen, L; Foulkes, W; Desrochers, M; Simard, J; Phelan, CM; Kwan, E; Narod, SA; Vahteristo, P; Nevanlinna, H; Durando, X; Bignon, YJ; Peyrat, JP; Bonnardel, C; Sinilnikova, OM; Puget, N; Lenoir, GM; Mazoyer, S; Audoynaud, C; Goldgar, D; Maugard, C; Caux, V; Gad, S; Stoppa-Lyonnet, D; Nogues, C; Lidereau, R; Machavoine, C; Bressac-de Paillerets, B; Kuschel, B; Betz, B; Niederacher, D; Beckmann, MW; Hamann, U; Gayther, SA; Ponder, BAP; Robinson, M; Taylor, GR; Bishop, T; Catteau, A; Solomon, E; Cohen, B; Steel, M; Collins, N; Stratton, M; van der Looij, M; Olah, E; Miller, NJ; Barton, DE; Sverdlov, RS; Friedman, E; Radice, P; Montagna, M; Sensi, E; Caligo, M; van Eijk, R; Devilee, P; van der Luijt, R; Heimdal, K; Moller, P; Borg, A; Diez, O; Cortes, J; Domenech, M; Baiget, M; Osorio, A; Benitez, J; Borg, A; Maillet, P; Sappino, AP; Ozdag, H; Ozcelik, T; Ozturk, M; Rohlfs, EM; Boyd, J; McDermott, D; Offit, K; Unger, M; Nathanson, K; Weber, BL; Sellers, TA; Hampton, E; Couch, FJ; Neuhausen, S
      The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations

      AMERICAN JOURNAL OF HUMAN GENETICS
    44. Borg, A; Sandberg, T; Nilsson, K; Johannsson, O; Klinker, M; Masback, A; Westerdahl, J; Olsson, H; Ingvar, C
      High frequency of multiple melanomas and breast and pancreas carcinomas inCDKN2A mutation-positive melanoma families

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    45. TIRKKONEN M; KAINU T; LOMAN N; JOHANNSSON OT; OLSSON H; BARKARDOTTIR RB; KALLIONIEMI OP; BORG A
      SOMATIC GENETIC ALTERATIONS IN BRCA2-ASSOCIATED AND SPORADIC MALE BREAST-CANCER

      Genes chromosomes & cancer (Print)
    46. Jarvinen, TAH; Tanner, M; Barlund, M; Borg, A; Isola, J
      Characterization of topoisomerase II alpha gene amplification and deletionin breast cancer

      GENES CHROMOSOMES & CANCER
    47. Laake, K; Launonen, V; Niederacher, D; Gudlaugsdottir, S; Seitz, S; Rio, P; Champeme, MH; Bieche, I; Birnbaum, D; White, G; Sztan, M; Sever, N; Plummer, S; Osorio, A; Broeks, A; Huusko, P; Spurr, N; Borg, A; Cleton-Jansen, AM; van't Veer, L; Benitez, J; Casey, G; Peterlin, B; Olah, E; Varley, J; Bignon, YJ; Scherneck, S; Sigurdardottir, V; Lidereau, R; Eyfjord, J; Beckmann, MW; Winqvist, R; Skovlund, E; Borresen-Dale, AL
      Loss of heterozygosity at 11q23.1 and survival in breast cancer: Results of a large European study

      GENES CHROMOSOMES & CANCER
    48. Persson, K; Pandis, N; Mertens, F; Borg, A; Baldetorp, B; Killander, D; Isola, J
      Chromosomal aberrations in breast cancer: A comparison between cytogenetics and comparative genomic hybridization

      GENES CHROMOSOMES & CANCER
    49. Koul, A; Nilbert, M; Borg, A
      A somatic BRCA2 mutation in RER+ endometrial carcinomas that specifically deletes the amino-terminal transactivation domain

      GENES CHROMOSOMES & CANCER
    50. Johannsson, O; Loman, N; Moller, T; Kristoffersson, U; Borg, A; Olsson, H
      Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers

      EUROPEAN JOURNAL OF CANCER
    51. Nilbert, M; Planck, M; Fernebro, E; Borg, A; Johnson, A
      Microsatellite instability is rare in rectal carcinomas and signifies hereditary cancer

      EUROPEAN JOURNAL OF CANCER
    52. Wagner, T; Stoppa-Lyonnet, D; Fleischmann, E; Muhr, D; Pages, S; Sandberg, T; Caux, V; Moeslinger, R; Langbauer, G; Borg, A; Oefner, P
      Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations

      GENOMICS
    53. Borg, A; Dorum, A; Heimdal, K; Maehle, L; Hovig, E; Moller, P
      BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations

      DISEASE MARKERS
    54. Bergthorsson, JT; Winther, K; Fenger, K; Niebuhr, A; Klausen, S; Borg, A; Harboe, T; Ejlertsen, B; Niebuhr, E
      Mutations of the BRCA1 and BRCA2 genes in Danish patients diagnosed at young age with multi-centric or bilateral breast cancer

      DISEASE MARKERS
    55. Moller, P; Borg, A; Evans, G; Haites, N; Steel, CM; Vasen, H; Gregory, H; Hodgson, S; Apold, J; Lalloo, F; Maehle, L; Anderson, E; Heimdal, K
      Mutation-specific survival of inherited breast cancer

      DISEASE MARKERS
    56. Moller, P; Evans, G; Haites, N; Vasen, H; Reis, MM; Anderson, E; Apold, J; Hodgson, S; Eccles, D; Olsson, H; Stoppa-Lyonnet, D; Chang-Claude, J; Morrison, PJ; Bevilacqua, G; Heimdal, K; Maehle, L; Lalloo, F; Gregory, H; Preece, P; Borg, A; Nevin, NC; Caligo, M; Steel, CM
      Guidelines for follow-up of women at high risk for inherited breast cancer: Consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer

      DISEASE MARKERS
    57. Worren, T; Ramsvik, T; Borg, A
      Homoepitaxial growth of Co on Co(11(2)over-bar-0) studied by STM

      APPLIED SURFACE SCIENCE
    58. Jernstrom, HCB; Johannsson, OT; Loman, N; Borg, A; Olsson, H
      Reproductive factors in hereditary breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    59. Ramstad, A; Strisland, F; Raaen, S; Borg, A; Berg, C
      CO and O-2 adsorption on the Re/Pt(111) surface studied by photoemission and thermal desorption.

      SURFACE SCIENCE
    60. Ramstad, A; Strisland, F; Raaen, S; Worren, T; Borg, A; Berg, C
      Growth and alloy formation studied by photoelectron spectroscopy and STM

      SURFACE SCIENCE
    61. Planck, M; Koul, A; Fernebro, E; Borg, A; Kristoffersson, U; Olsson, H; Wenngren, E; Mangell, P; Nilbert, M
      hMLH1, hMSH2 and hMSH6 mutations in hereditary non-polyposis colorectal cancer families from Southern Sweden

      INTERNATIONAL JOURNAL OF CANCER
    62. Loman, N; Johannsson, O; Bendahl, PO; Borg, A; Ferno, M; Olsson, H
      Steroid receptors in hereditary breast carcinomas associated with BRCA1 orBRCA2 mutations or unknown susceptibility genes - Reply

      CANCER
    63. Bratt, O; Borg, A; Kristoffersson, U; Lundgren, R; Zhang, QX; Olsson, H
      CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk

      BRITISH JOURNAL OF CANCER
    64. Launonen, V; Laake, K; Huusko, P; Niederacher, D; Beckmann, MW; Barkardottir, RB; Geirsdottir, EK; Gudmundsson, J; Rio, P; Bignon, YJ; Seitz, S; Scherneck, S; Bieche, I; Champeme, MH; Birnbaum, D; White, G; Varley, J; Sztan, M; Olah, E; Osorio, A; Benitez, J; Spurr, N; Velikonja, N; Peterlin, B; Borg, A; Cleton-Jansen, AM; Devilee, P; Bloigu, R; Lidereau, R; Borresen-Dale, AL; Winqvist, R
      European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables

      BRITISH JOURNAL OF CANCER
    65. Fioretos, T; Strombeck, B; Sandberg, T; Johansson, B; Billstrom, R; Borg, A; Nilsson, PG; Van Den Berghe, H; Hagemeijer, A; Mitelman, F; Hoglund, M
      Isochromosome 17q in blast crisis of chronic myeloid leukemia and in otherhematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations

      BLOOD
    66. Koul, A; Malander, S; Ridderheim, M; Borg, A
      BRCA1 and BRCA2 mutations in ovarian cancer: covariation with specific cytogenetic features

      7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY
    67. BERGTHORSSON JT; JONASDOTTIR A; JOHANNESDOTTIR G; ARASON A; EGILSSON V; GAYTHER S; BORG A; HAKANSON S; INGVARSSON S; BARKARDOTTIR RB
      IDENTIFICATION OF A NOVEL SPLICE-SITE MUTATION OF THE BRCA1 GENE IN 2BREAST-CANCER FAMILIES - SCREENING REVEALS LOW-FREQUENCY IN ICELANDICBREAST-CANCER PATIENTS

      Human mutation
    68. LEES M; TABRIZI S; GUST C; JACKSON H; BORG A; CHEN SJ; MIGLIORINI G; GARLAND S
      DETECTION OF CHLAMYDIA-TRACHOMATIS IN A LOW-PREVALENCE FEMALE-POPULATION USING ROCHE AMPLICOR PCR, PHARMACIA EIA AND TISSUE-CULTURE

      Venereology
    69. Jernstrom, H; Johannsson, O; Borg, A; Olsson, H
      Do BRCA1 mutations affect the ability to breast-feed? Significantly shorter length of breast-feeding among BRCA1 mutation carriers compared with their unaffected relatives

      BREAST
    70. JERNSTROM H; JOHANNSSON O; BORG A; IVARSSON H; OLSSON H
      BRCA1-POSITIVE PATIENTS ARE SMALL-FOR-GESTATIONAL-AGE COMPARED WITH THEIR UNAFFECTED RELATIVES

      European journal of cancer
    71. VENVIK HJ; BORG A
      THE (2X5)-CARBON OVERLAYER STRUCTURE ON CO(11(2)OVER-BAR-0) STUDIED BY STM

      Applied physics A: Materials science & processing
    72. Devilee, P; Barkardottir, RB; Bevilacqua, G; Bignon, YJ; Bishop, T; Borg, A; Borresen-Dale, AL; Chang-Claude, J; Easton, D; Eyfjord, J; Feunteun, J; Goldgar, D; Haites, N; Holm, N; Kruse, T; Larsson, C; Lenoir, G; Lidereau, R; Nevanlinna, H; Ponder, B; Scherneck, S; Schmitt, F; Sobol, H; Solomon, E; Spurr, N; Steel, M; Stratton, M; Varley, J; Vasen, H; Vassilaros, S; Wagner, T; Willems, P; Winqvist, R
      Genetics and epidemiology of hereditary breast cancer

      CANCER RESEARCH SUPPORTED UNDER BIOMED I
    73. JOHANNSSON OT; RANSTAM J; BORG A; OLSSON H
      SURVIVAL OF BRCA1 BREAST AND OVARIAN-CANCER PATIENTS - A POPULATION-BASED STUDY FROM SOUTHERN SWEDEN

      Journal of clinical oncology
    74. JOHANNSSON O; LOMAN N; BORG A; OLSSON H
      PREGNANCY-ASSOCIATED BREAST-CANCER IN BRCA1 AND BRCA2 GERMLINE MUTATION CARRIERS

      Lancet
    75. STRISLAND F; RAMSTAD A; RAMSVIK T; BORG A
      CO ADSORPTION ON THE RH(100) SURFACE STUDIED BY HIGH-RESOLUTION PHOTOELECTRON-SPECTROSCOPY

      Surface science
    76. BERG C; VENVIK HJ; STRISLAND F; RAMSTAD A; BORG A
      NUCLEATION AND GROWTH OF AU OVERLAYERS ON PT(100)-HEX-R0.7-DEGREES STUDIED BY STM AND PHOTOELECTRON-SPECTROSCOPY

      Surface science
    77. VENVIK HJ; BERG C; BORG A
      CO ADSORPTION ON CO(10(1)OVER-BAR-2) - A STM STUDY

      Surface science
    78. VENVIK HJ; BORG A; BERG C
      FORMATION OF THE GO-INDUCED (3X1) SURFACE-STRUCTURE ON CO(11(2)OVER-BAR0) STUDIED BY STM

      Surface science
    79. WAGNER TMU; MOSLINGER RA; MUHR D; LANGBAUER G; HIRTENLEHNER K; CONCIN H; DOELLER W; HAID A; LANG AH; MAYER P; ROPP E; KUBISTA E; AMIRIMANI B; HELBICH T; BECHERER A; SCHEINER O; BREITENEDER H; BORG A; DEVILEE P; OEFNER P; ZIELINSKI C
      BRCA1-RELATED BREAST-CANCER IN AUSTRIAN BREAST AND OVARIAN-CANCER FAMILIES - SPECIFIC BRCA1 MUTATIONS AND PATHOLOGICAL CHARACTERISTICS

      International journal of cancer
    80. HARALDSSON K; LOMAN N; ZHANG QX; JOHANNSSON O; OLSSON H; BORG A
      BRCA2 GERM-LINE MUTATIONS ARE FREQUENT IN MALE BREAST-CANCER PATIENTSWITHOUT A FAMILY HISTORY OF THE DISEASE

      Cancer research
    81. PHELAN CM; BORG A; CUNY M; CRICHTON DN; BALDERSSON T; ANDERSEN TI; CALIGO MA; LIDEREAU R; LINDBLOM A; SEITZ S; KELSELL D; HAMANN K; RIO P; THORLACIUS S; PAPP J; OLAH E; PONDER B; BIGNON YJ; SCHERNECK S; BARKARDOTTIR R; BORRESENDALE AL; EYFJORD J; THEILLET C; THOMPSON AM; DEVILEE P; LARSSON C
      CONSORTIUM STUDY ON 1280 BREAST CARCINOMAS - ALLELIC LOSS ON CHROMOSOME-17 TARGETS SUBREGIONS ASSOCIATED WITH FAMILY HISTORY AND CLINICAL-PARAMETERS

      Cancer research
    82. LOMAN N; JOHANNSSON O; BENDAHL PO; BORG A; FERNO M; OLSSON H
      STEROID-RECEPTORS IN HEREDITARY BREAST CARCINOMAS ASSOCIATED WITH BRCA1 OR BRCA2 MUTATIONS OR UNKNOWN SUSCEPTIBILITY GENES

      Cancer
    83. MINETA H; BORG A; DICTOR M; WAHLBERG P; AKERVALL J; WENNERBERG J
      P53 MUTATION, BUT NOT P53 OVEREXPRESSION, CORRELATES WITH SURVIVAL INHEAD AND NECK SQUAMOUS-CELL CARCINOMA

      British Journal of Cancer
    84. TANNER MM; KARHU RA; NUPPONEN NN; BORG A; BALDETORP B; PEJOVIC T; FERNO M; KILLANDER D; ISOLA JJ
      GENETIC ABERRATIONS IN HYPODIPLOID BREAST-CANCER - FREQUENT LOSS OF CHROMOSOME-4 AND AMPLIFICATION OF CYCLIN D1 ONCOGENE

      The American journal of pathology
    85. NEUHAUSEN SL; GODWIN AK; GERSHONIBARUCH R; SCHUBERT E; GARBER J; STOPPALYONNET D; OLAH E; CSOKAY B; SEROVA O; LALLOO F; OSORIO A; STRATTON M; OFFIT K; BOYD J; CALIGO MA; SCOTT RJ; SCHOFIELD A; TEUGELS E; SCHWAB M; CANNONALBRIGHT L; BISHOP T; EASTON D; BENITEZ J; KING MC; PONDER BAJ; WEBER B; DEVILEE P; BORG A; NAROD SA; GOLDGAR D
      HAPLOTYPE AND PHENOTYPE ANALYSIS OF 9 RECURRENT BRCA2 MUTATIONS IN 111 FAMILIES - RESULTS OF AN INTERNATIONAL STUDY

      American journal of human genetics
    86. FORD D; EASTON DF; STRATTON M; NAROD S; GOLDGAR D; DEVILEE P; BISHOP DT; WEBER B; LENOIR G; CHANGCLAUDE J; SOBOL H; TEARE MD; STRUEWING J; ARASON A; SCHERNECK S; PETO J; REBBECK TR; TONIN P; NEUHAUSEN S; BARKARDOTTIR R; EYFJORD J; LYNCH H; PONDER BAJ; GAYTHER SA; BIRCH JM; LINDBLOM A; STOPPALYONNET D; BIGNON Y; BORG A; HAMANN U; HAITES N; SCOTT RJ; MAUGARD CM; VASEN H
      GENETIC-HETEROGENEITY AND PENETRANCE ANALYSIS OF THE BRCA1 AND BRCA2 GENES IN BREAST-CANCER FAMILIES

      American journal of human genetics
    87. MINETA H; BORG A; DICTOR M; WAHLBERG P; WENNERBERG J
      CORRELATION BETWEEN P53 MUTATION AND CYCLIN D1 AMPLIFICATION IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA

      Oral Oncology
    88. DEVILEE P; HERMANS J; EYFJORD J; BORRESEN AL; LIDEREAU R; SOBOL H; BORG A; CLETONJANSEN AM; OLAH E; COHEN B; SCHERNECK S; HAMANN U; PETERLIN B; CALIGO M; BIGNON YL; MAUGARD C; ANDERSEN TI; ODEGAND AEM; BIECHE I; BIRNBAUM D; CORNELISSE CJ; SZTAN M; STEEL MR; SEITZ S; LOGAR N; GOLOUH R; GHIMENTI C; BRUELLE S; JOALLAND MP
      LOSS OF HETEROZYGOSITY AT 7Q31 IN BREAST-CANCER - RESULTS FROM AN INTERNATIONAL COLLABORATIVE STUDY-GROUP

      Genes, chromosomes & cancer
    89. JERNSTROM HCB; OLSSON H; BORG A
      REDUCED TESTOSTERONE, 17-BETA-ESTRADIOL AND SEXUAL HORMONE-BINDING GLOBULIN, AND INCREASED INSULIN-LIKE GROWTH-FACTOR-I CONCENTRATIONS, IN HEALTHY NULLIGRAVID WOMEN AGED 19-25 YEARS WHO WERE FIRST AND OR 2ND-DEGREE RELATIVES TO BREAST-CANCER PATIENTS/

      European journal of cancer prevention
    90. JOHANNSSON OT; IDVALL I; ANDERSON C; BORG A; BARKARDOTTIR RB; EGILSSON V; OLSSON H
      TUMOR BIOLOGICAL FEATURES OF BRCA1-INDUCED BREAST AND OVARIAN-CANCER

      European journal of cancer
    91. YIN H; MEDSTRAND P; ANDERSSON ML; BORG A; OLSSON H; BLOMBERG J
      TRANSCRIPTION OF HUMAN ENDOGENOUS RETROVIRAL SEQUENCES RELATED TO MOUSE MAMMARY-TUMOR VIRUS IN HUMAN BREAST AND PLACENTA - SIMILAR PATTERN IN MOST MALIGNANT AND NONMALIGNANT BREAST TISSUES

      AIDS research and human retroviruses
    92. CHAO KA; BORG A; FIMLAND BO; FJELDLY TA
      PROCEEDINGS OF 17TH-NORDIC-SEMICONDUCTOR-MEETING - TRONDHEIM, NORWAY,JUNE 17-20, 1996 - PREFACE

      Physica scripta. T
    93. HEDENFALK IA; BALDETORP B; BORG A; OREDSSON SM
      ACTIVATED CELL-CYCLE CHECKPOINTS IN EPIRUBICIN-TREATED BREAST-CANCER CELLS STUDIED BY BRDURD-FLOW CYTOMETRY

      Cytometry
    94. BORG A; PIHL L; WENNHAGE H
      HABITAT CHOICE BY JUVENILE COD (GADUS-MORHUA L.) ON SANDY SOFT BOTTOMS WITH DIFFERENT VEGETATION TYPES

      Helgolander Meeresuntersuchungen
    95. RITZ G; SCHMID M; VARGA P; BORG A; RONNING M
      PT(100) QUASI-HEXAGONAL RECONSTRUCTION - A COMPARISON BETWEEN SCANNING-TUNNELING-MICROSCOPY DATA AND EFFECTIVE-MEDIUM THEORY SIMULATION CALCULATIONS

      Physical review. B, Condensed matter
    96. KOUL A; BORG A; PEJOVIC T; BENDAHL PO; HOGBERG T; IOSIF CS; KILLANDER D
      IDENTIFICATION OF TP53 GENE-MUTATIONS IN UTERINE CORPUS CANCER WITH SHORT FOLLOW-UP

      Gynecologic oncology
    97. JOHANNSSON O; RANSTAM J; BORG A; OLSSON H
      BRCA1 MUTATIONS AND SURVIVAL IN WOMEN WITH OVARIAN-CANCER

      The New England journal of medicine
    98. TIRKKONEN M; JOHANNSSON O; AGNARSSON BA; OLSSON H; INGVARSSON S; KARHU R; TANNER M; ISOLA J; BARKARDOTTIR RB; BORG A; KALLIONIEMI OP
      DISTINCT SOMATIC GENETIC CHANGES ASSOCIATED WITH TUMOR PROGRESSION INCARRIERS OF BRCA1 AND BRCA2 GERM-LINE MUTATIONS

      Cancer research
    99. ZHANG QX; BORG A; WOLF DM; OESTERREICH S; FUQUA SAW
      AN ESTROGEN-RECEPTOR MUTANT WITH STRONG HORMONE-INDEPENDENT ACTIVITY FROM A METASTATIC BREAST-CANCER

      Cancer research
    100. ZELADAHEDMAN M; ARVER BW; CLARO A; CHEN JD; WERELIUS B; KOK H; SANDELIN K; HAKANSSON S; ANDERSEN TI; BORG A; DALE ALB; LINDBLOM A
      A SCREENING FOR BRCA1 MUTATIONS IN BREAST AND BREAST-OVARIAN CANCER FAMILIES FROM THE STOCKHOLM REGION

      Cancer research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 04:03:47